<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comentarios en: Centocor Ortho Biotech Statement On The FDA ODAC Opinion Regarding Trabectedin For Relapsed Ovarian Cancer</title>
	<atom:link href="http://impotenmasculina.com/impotencia/articles/centocor-ortho-biotech-statement-on-the-fda-odac-opinion-regarding-trabectedin-for-relapsed-ovarian-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>http://impotenmasculina.com/impotencia/articles/centocor-ortho-biotech-statement-on-the-fda-odac-opinion-regarding-trabectedin-for-relapsed-ovarian-cancer/</link>
	<description>Otro blog más de WordPress</description>
	<pubDate>Thu, 09 Sep 2010 14:17:42 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.1</generator>
	</channel>
</rss>
